MeSH term
Frequency | Condition_Probility | Aged | 9 | 0.0 |
Comparative Study | 22 | 0.0 |
Female | 19 | 0.0 |
Humans | 127 | 0.0 |
Male | 17 | 0.0 |
Middle Aged | 9 | 0.0 |
Antifungal Agents/pharmacology | 3 | 7.0 |
Base Sequence | 52 | 0.0 |
Drug Resistance, Fungal/*genetics | 2 | 25.0 |
Fluconazole/pharmacology | 2 | 14.0 |
*Fungal Proteins | 3 | 8.0 |
Research Support, Non-U.S. Gov't | 92 | 0.0 |
Amino Acid Sequence | 78 | 0.0 |
Animals | 62 | 0.0 |
Cloning, Molecular | 16 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Models, Molecular | 18 | 0.0 |
Molecular Sequence Data | 89 | 0.0 |
Protein Binding | 7 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Sequence Alignment | 13 | 0.0 |
Sequence Analysis, DNA | 10 | 0.0 |
Sequence Homology, Amino Acid | 22 | 0.0 |
Complementarity Determining Regions/genetics | 4 | 19.0 |
Consensus Sequence | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
*Genes, Immunoglobulin | 14 | 7.0 |
Immunoglobulin Variable Region/*genetics | 16 | 15.0 |
Immunoglobulins, Heavy-Chain/*genetics | 15 | 10.0 |
Leukemia, B-Cell, Chronic/*genetics/metabolism/pathology | 2 | 40.0 |
*Mutation | 7 | 0.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Sequence Homology, Nucleic Acid | 7 | 0.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
Gene Library | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Estradiol/pharmacology | 2 | 0.0 |
Antibody Diversity | 5 | 33.0 |
Cattle | 5 | 0.0 |
Complementarity Determining Regions/*genetics | 2 | 28.0 |
DNA/genetics | 3 | 0.0 |
Fetus/*immunology | 2 | 4.0 |
Hybridomas | 2 | 1.0 |
Immunoglobulin Joining Region/genetics | 2 | 9.0 |
Immunoglobulin Variable Region/genetics | 7 | 6.0 |
Immunoglobulins, Heavy-Chain/genetics | 6 | 3.0 |
Mice | 43 | 0.0 |
Mutation | 12 | 0.0 |
Species Specificity | 2 | 0.0 |
Biological Transport | 3 | 0.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
DNA, Neoplasm/analysis | 4 | 0.0 |
Gene Rearrangement | 2 | 0.0 |
Genes, Immunoglobulin/*genetics | 8 | 19.0 |
Immunohistochemistry | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Immunoglobulins, Light-Chain/genetics | 3 | 8.0 |
Multiple Myeloma/*genetics | 2 | 4.0 |
Adult | 7 | 0.0 |
Immunophenotyping | 3 | 0.0 |
Blotting, Southern | 5 | 0.0 |
Phylogeny | 5 | 0.0 |
Cerulenin/pharmacology | 2 | 100.0 |
Drug Resistance, Microbial/genetics | 6 | 6.0 |
Fluconazole/*pharmacology | 2 | 13.0 |
Japan | 2 | 0.0 |
*Membrane Transport Proteins | 4 | 0.0 |
Microbial Sensitivity Tests | 9 | 3.0 |
Cell Line, Tumor | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Neutralization Tests | 2 | 0.0 |
*Peptide Library | 2 | 3.0 |
Colony Count, Microbial | 2 | 2.0 |
Rats | 4 | 0.0 |
Cell Line | 11 | 0.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
CHO Cells | 4 | 0.0 |
Hamsters | 4 | 0.0 |
Ligands | 4 | 0.0 |
ATP-Binding Cassette Transporters/*genetics | 2 | 0.0 |
*Genes, Fungal | 2 | 1.0 |
Genetic Complementation Test | 2 | 0.0 |
ATP-Binding Cassette Transporters/genetics/metabolism | 2 | 7.0 |
Antifungal Agents/*pharmacology | 5 | 10.0 |
Blotting, Northern | 4 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Clone Cells | 7 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Adolescent | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Antibody Affinity | 4 | 2.0 |
Binding Sites, Antibody | 5 | 1.0 |
Kinetics | 5 | 0.0 |
Peptide Library | 2 | 1.0 |
Binding Sites | 7 | 0.0 |
Mutagenesis | 3 | 0.0 |
Thermodynamics | 2 | 0.0 |
Candidiasis, Oral/microbiology | 2 | 25.0 |
Gene Frequency | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Antigens, Neoplasm/*immunology | 2 | 1.0 |
Immunoglobulin Idiotypes/*immunology | 3 | 7.0 |
Immunoglobulin Variable Region/*immunology | 3 | 15.0 |
Immunoglobulins, Heavy-Chain/*immunology | 3 | 42.0 |
Peptides/immunology | 4 | 2.0 |
T-Lymphocytes/immunology | 5 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Spodoptera/cytology | 2 | 4.0 |
Immunoglobulin Variable Region/chemistry/*genetics | 3 | 75.0 |
Macromolecular Substances | 4 | 0.0 |
Mutagenesis, Site-Directed | 17 | 0.0 |
Protein Binding/immunology | 2 | 1.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Antibodies, Monoclonal/genetics/*metabolism | 2 | 66.0 |
Binding Sites, Antibody/genetics | 3 | 23.0 |
Immunoglobulin Variable Region/genetics/*metabolism | 2 | 100.0 |
Peptide Fragments/genetics/*immunology/metabolism | 2 | 33.0 |
DNA, Complementary/genetics | 5 | 0.0 |
Mice, Inbred BALB C | 6 | 0.0 |
Drug Resistance, Microbial/*genetics | 2 | 10.0 |
Drug Resistance, Multiple/*genetics | 2 | 3.0 |
Genotype | 2 | 0.0 |
Antigens/metabolism | 2 | 3.0 |
*Complementarity Determining Regions | 2 | 25.0 |
In Vitro | 5 | 0.0 |
Antibody Specificity | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Genes, Immunoglobulin | 6 | 3.0 |
Hybridomas/immunology | 2 | 1.0 |
Lupus Erythematosus, Systemic/genetics/*immunology | 3 | 9.0 |
HIV-1/*immunology | 2 | 0.0 |
Computer Simulation | 2 | 0.0 |
Immunoglobulins, Light-Chain/chemistry | 2 | 28.0 |
Protein Conformation | 8 | 0.0 |
Rabbits | 5 | 0.0 |
Structure-Activity Relationship | 11 | 0.0 |
*Protein Conformation | 2 | 0.0 |
Superantigens/*immunology | 3 | 3.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Vaccines, Synthetic/immunology | 2 | 6.0 |
Fungal Proteins/genetics | 2 | 1.0 |
Gene Expression Regulation, Fungal | 2 | 2.0 |
*Chromosome Mapping | 2 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Receptors, Antigen, T-Cell, alpha-beta/*genetics | 3 | 4.0 |
B-Lymphocytes/immunology | 4 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Receptors, Antigen, T-Cell, alpha-beta/*chemistry/metabolism | 2 | 66.0 |
Immunoglobulin Variable Region/*chemistry/genetics | 3 | 50.0 |
Immunoglobulins, Heavy-Chain/*chemistry/genetics | 2 | 50.0 |
Temperature | 2 | 0.0 |
Receptors, Antigen, T-Cell/*immunology | 2 | 1.0 |
Codon | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Immunoglobulins, lambda-Chain/*genetics | 3 | 18.0 |
Genetic Vectors | 4 | 0.0 |
Glycosylation | 3 | 0.0 |
Transfection | 5 | 0.0 |
Alleles | 4 | 0.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Epitope Mapping | 3 | 1.0 |
Major Histocompatibility Complex | 2 | 0.0 |
*Antigen-Antibody Reactions | 2 | 5.0 |
*Binding Sites, Antibody | 3 | 8.0 |
Keratin/analysis | 2 | 0.0 |
*Antibody Affinity | 2 | 11.0 |
Antigen-Antibody Reactions | 4 | 1.0 |
Hydrogen Bonding | 2 | 1.0 |
Sequence Analysis | 2 | 0.0 |
Spleen/*immunology | 2 | 9.0 |
DNA Primers | 2 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Oligonucleotide Probes | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Binding Sites, Antibody/*genetics | 3 | 75.0 |
Models, Biological | 2 | 0.0 |
Antibodies, Monoclonal/chemistry/immunology | 2 | 18.0 |
Cells, Cultured | 3 | 0.0 |
HIV Envelope Protein gp120/metabolism | 2 | 1.0 |
B-Lymphocytes/*immunology | 3 | 0.0 |
*Evolution | 2 | 1.0 |
Peptide Fragments/*immunology | 2 | 1.0 |
DNA/analysis | 3 | 0.0 |
HLA-DR Antigens/*immunology | 2 | 1.0 |
Lymphocyte Activation | 3 | 0.0 |
Autoimmune Diseases/*immunology | 2 | 1.0 |
Cross Reactions | 3 | 0.0 |
*Alleles | 2 | 0.0 |
Nucleic Acid Hybridization | 5 | 0.0 |
Epitopes/chemistry/genetics | 2 | 9.0 |
Antibodies, Monoclonal/*immunology | 3 | 0.0 |
Antigens, CD4/*immunology | 2 | 0.0 |
Immunoglobulin Variable Region/immunology | 2 | 6.0 |
Molecular Structure | 3 | 0.0 |
Antigens, CD4/*metabolism | 2 | 0.0 |
*Antibody Diversity | 3 | 75.0 |
Haemophilus influenzae/*immunology | 2 | 8.0 |
Polysaccharides, Bacterial/*immunology | 2 | 8.0 |
Multigene Family | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
HIV Envelope Protein gp120 | 2 | 3.0 |
Receptors, HIV | 2 | 3.0 |
DNA/isolation & purification | 2 | 1.0 |
*Cloning, Molecular | 2 | 0.0 |
Genes, Structural | 3 | 0.0 |
*Genes, Structural | 3 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
Dimerization | 2 | 0.0 |
